Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Franklin: The growth of Solana may continue, solidifying its position as the third largest cryptocurrency

Franklin: The growth of Solana may continue, solidifying its position as the third largest cryptocurrency

Bitget2024/05/03 04:23

May 3rd news, Franklin Templeton released a report on Solana, suggesting that the growth of Solana could continue, solidifying its position as the third largest cryptocurrency after BTC and ETH. The crypto activity of Solana began to accelerate in the fourth quarter of 2023 when an airdrop within the Solana ecosystem created over $1 billion wealth effect, driving up SOL and other ecosystem tokens, especially Meme coins; Areas most likely to bring about the next wave of adoption for Solana include DePIN, payments (especially micropayments), compressed NFTs, xNFTs and CLOB (Centralized Limit Order Book)/order flow payments etc.; A major catalyst to solve congestion issues due to high demand is Firedancer - a Solana validator client developed by Jump Crypto which will be launched later this year.

1
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Moderna plunges by as much as 26%, setting a record for the biggest single-day drop! Melanoma vaccine data leaked early, results fall short of expectations

Clinical trial data from phase 3 of the personalized melanoma vaccine jointly developed by Moderna and Merck was unexpectedly leaked ahead of schedule. The data showed a 42% reduction in cancer recurrence risk and a 38% reduction in risk of distant metastasis. These results fell short of market expectations, as an earlier study had shown the combination therapy could reduce recurrence risk by 49% and distant metastasis risk by 59%. Moderna's stock price plunged as much as 26% intraday, later rebounded partially, and ultimately closed down 17.6%.

华尔街见闻•2026/10/22 21:01